Cellphire Therapeutics, Inc. is a Rockville, Maryland-based biotechnology company developing next-generation therapeutics. The company is applying its proprietary cell stabilization technology to all cell types, including platelets, to develop lifesaving products. Its lead product, Thrombosomes?, a freeze-dried hemostatic agent derived from human platelets, is currently in a Phase I clinical trial. Cellphire’s technology has potential applications across a wide range of medical applications from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine.
Cellphire Therapeutics, Inc.的外部链接
9430 Key West Ave
US，Maryland，Rockville，20850
Cellphire Therapeutics, Inc.转发了
Wow! A big congratulations to the Cellphire Therapeutics, Inc. team, our CRYPTICS investigatory team, and our partners for the hard work and progress behind FDA Fast Track designation just received for our Frozen Platelet Product - CLPH-511. https://lnkd.in/eKJrZ8Xd Thank you to the Defense Health Agency for your partnership in developing this product to approval!
We’re thrilled to share that Cellphire Therapeutics has reached a major milestone in our Phase 2/3 CRYPTICS clinical study! This achievement is a testament to the dedication of our team, the support of our partners, and the potential of platelet-based technology to improve patient outcomes. Thank you to everyone who has contributed to this journey! Stay tuned as we continue to push the boundaries of science and innovation. Read more: https://lnkd.in/eRpsQqt4 #Cellphire #Biotech #ClinicalTrials #Innovation #Healthcare #PlateletTechnology
Cellphire Therapeutics, Inc.转发了
Please join us during the poster sessions at MHSRS. We are excited for the opportunity to share our innovative work and receive your comments. (MHSRS-24-11477) Cryopreserved Platelets Prepared by Novel Allogenic Pooling and Post-Thaw Processes are Stable at Elevated Temperatures. This indicates it may be possible to store CPP at -20C. (MHSRS-24-11499) A Freeze-Dried Platelet-Derived Hemostatic Agent is Partially Resistant to Fibrinolysis In Vitro. This poster shows longer lasting clots may result from FPH Resistance to Fibrinolysis.
Message from our CEO, Mike Gaffney: I’m sharing an important thank you with the LinkedIn community.?On behalf of myself, the entire Cellphire Therapeutics, Inc. team, and our Board of Directors I am extending our deepest gratitude to Dr. Allan Alexander for his remarkable contributions as our Chief Medical Officer. Allan’s passion for patients, clinical development expertise, and unwavering commitment to our vision of saving lives have been instrumental in progressing our Phase 2 products toward approval.?Unfortunately for Cellphire, Allan will be taking a step back to help members of his family dealing with some significant health challenges. As Allan steps back from his current role to take care of his family, we are immensely grateful for his decision to remain with us in a strategic clinical advisory capacity. His deep understanding of our products and his passion for improving patient outcomes will continue to guide us as we navigate the path to licensure and adoption of our therapeutics. Allan, your hard work and invaluable insights have left an indelible mark on Cellphire. We look forward to your ongoing guidance and support. Thank you for everything you have done and will continue to do for our team and our mission. #Cellphire #Team #ThankYou
We are thrilled to welcome Dr. Damien Bates MD, PhD, FRACS, MBA to the Cellphire team as our new Chief Medical Officer! Dr. Bates brings a wealth of experience and expertise in clinical development and strategic leadership. With a distinguished career spanning over two decades, his leadership and vision will be instrumental as we continue to innovate and advance our corporate vision of saving lives through cutting-edge biotechnology. Welcome to the team, Dr. Bates! We are excited to achieve great things together. #NewHire #TeamCellphire #ChiefMedicalOfficer #Biotechnology #Innovation #Leadership #Healthcare
Cellphire Therapeutics acknowledges Rigshospitalet Copenhagen University Hospital for completing enrollment ahead of schedule in their study of Thrombosomes? (FPH) for Acute Aortic Dissections, marking a significant step forward in life-saving cellular therapeutics. Dr. Jakob Stensballe and Dr. Annette Ulrich led the Copenhagen team's exceptional effort, demonstrating a shared commitment to innovation and patient care, with optimism for the potential impact of FPH technology on improving patient outcomes. #Platelets #SaveLives #CompletedEnrollment #FPH #ClinicalStudy
Mark your calendar! Our CEO, Mike Gaffney, takes the stage at the prestigious BIO International Convention at 2:15pm today. Head to Company Presentation Theater 3 - Hall A of the BIO Exhibition Hall to witness firsthand the cutting-edge initiatives and groundbreaking strides we're making in the biotech realm. Mike's presentation will provide invaluable insights into our latest innovations and developments. Don't miss out on this opportunity to be part of the conversation! #BIO2024 #biotech #innovation #CEOInsights #SaveLives #Platelets #Cellphire
Our CEO, Mike Gaffney, will be representing Cellphire at BIO International 2024 in San Diego from June 3-6! Join us as we showcase our cutting-edge products. Don't miss out on this opportunity to connect and explore the possibilities together. See you there! #biotech #platelets #Cellphire #Bio2024
We are excited to announce a strategic partnership with Vitalant, one of the nation’s largest nonprofit blood and biotherapies healthcare organizations. The partnership includes an initial investment by Vitalant and support for Cellphire's product development and clinical manufacturing processes of freeze-dried platelet derived hemostat (FPH) and Cryopreserved Platelets. #Partnership #Hemostasis #Biotech #Coagulation #Biopharmaceuticals #Innovation
Exciting news! Cellphire is on the lookout for a talented Assistant Controller to join our dynamic finance team! If you're passionate about numbers, thrive in a fast-paced environment, and are ready to make a meaningful impact, we want to hear from you. Apply now and be part of our journey towards success! #NowHiring #AssistantController #FinanceCareer